{"id":117,"date":"2025-10-27T05:40:26","date_gmt":"2025-10-27T09:40:26","guid":{"rendered":"https:\/\/www.cpd.utoronto.ca\/effectorcell\/?page_id=117"},"modified":"2026-02-11T08:52:40","modified_gmt":"2026-02-11T13:52:40","slug":"agenda","status":"publish","type":"page","link":"https:\/\/www.cpd.utoronto.ca\/effectorcell\/agenda\/","title":{"rendered":"Agenda"},"content":{"rendered":"

A question and answer period will follow each presentation. A minimum of 25% of each presentation will be allowed for Q & A<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
08:00<\/td>\n\n

Welcome and Introductions<\/span>
Christine Chen<\/em><\/span><\/p>\n<\/td>\n<\/tr>\n

08:10<\/td>\n\n

Challenges of Getting a Lymphoma Patient to CAR T<\/span>
Jeremy Abramson, Director of Centre for Lymphoma, Massachusetts General Hospital (MGH), Boston<\/em><\/span><\/p>\n<\/td>\n<\/tr>\n

08:50<\/td>\n\n

CAR T in Myeloma: What Have We Learned?<\/span>
Tom Martin University of California San Francisco (UCSF) Associate Director Myeloma Program<\/em><\/span><\/p>\n<\/td>\n<\/tr>\n

09:30<\/td>\n\n

CAR T-Cell Therapy for Autoimmune Disease<\/span>
Zahi Touma, UHN Head of Lupus Program<\/em><\/span><\/p>\n<\/td>\n<\/tr>\n

10:00<\/td>\n\n

Break<\/span><\/p>\n<\/td>\n<\/tr>\n

10:30-11:20<\/td>\n\n

Small Group Session A
Small group sessions are fully interactive between faculty and participants. For planning purposes, pre-registration for workshops is required. Participants are encouraged to bring cases and questions for discussion.<\/small><\/span><\/p>\n<\/td>\n<\/tr>\n

<\/td>\n\n

1) CAR T in Lymphoma<\/span>
A.Prica, J.Kuruvilla, I.Gong<\/em><\/span><\/p>\n<\/td>\n<\/tr>\n

<\/td>\n\n

2) CAR T in ALL<\/span>
H.Sibai, D.Eng<\/em><\/span><\/p>\n<\/td>\n<\/tr>\n

<\/td>\n\n

3) CAR T in Myeloma<\/span>
T.Martin, S.Bhella, R.Latscha<\/em><\/span><\/p>\n<\/td>\n<\/tr>\n

<\/td>\n\n

4) Longterm Follow-up Post-CAR T<\/span>
J. Abramson, C.Chen, A.Alshami, F.Binder<\/em><\/span><\/p>\n<\/td>\n<\/tr>\n

11:30-12:20<\/td>\n\n

Small Group Session B
Small group sessions are fully interactive between faculty and participants. For planning purposes, pre-registration for workshops is required. Participants are encouraged to bring cases and questions for discussion.<\/small><\/span><\/p>\n<\/td>\n<\/tr>\n

<\/td>\n\n

1) CAR T in Lymphoma<\/span>
A.Prica, J. Kuruvilla, I.Gong<\/em><\/span><\/p>\n<\/td>\n<\/tr>\n

<\/td>\n\n

2) CAR T in ALL<\/span>
H.Sibai, D.Eng<\/em><\/span><\/p>\n<\/td>\n<\/tr>\n

<\/td>\n\n

3) CAR T in Myeloma<\/span>
T.Martin, Drs. S.Bhella, R.Latscha<\/em><\/span><\/p>\n<\/td>\n<\/tr>\n

<\/td>\n\n

4) Longterm Follow-up Post-CAR T<\/span>
J. Abramson, C.Chen, A.Alshami, F.Binder<\/em><\/span><\/p>\n<\/td>\n<\/tr>\n

12:20<\/td>\n\n

Lunch break<\/span>
Lunch break<\/em><\/span><\/p>\n<\/td>\n<\/tr>\n

01:00<\/td>\n\n

Infections in CAR T 101<\/span>
Victoria Hall, UHN Oncology Infectious Diseases<\/em><\/span><\/p>\n<\/td>\n<\/tr>\n

01:30<\/td>\n\n

Tumor Infiltrating Lymphocytes (TILS) in Solid Tumor<\/span>
Marcus Butler, PM Tumor Immunotherapy Program<\/em><\/span><\/p>\n<\/td>\n<\/tr>\n

02:00<\/td>\n\n

Sequencing \u2013 CAR T vs Bispecifics in Lymphoma<\/span>
John Kuruvilla, PM Lymphoma Site Lead<\/em><\/span><\/p>\n<\/td>\n<\/tr>\n

02:30<\/td>\n\n

Closing Remarks<\/span>
Christine Chen<\/em><\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

A question and answer period will follow each presentation. A minimum of 25% of each presentation will be allowed for Q & A 08:00 Welcome and IntroductionsChristine Chen 08:10 Challenges of Getting a Lymphoma Patient to CAR TJeremy Abramson, Director of Centre for Lymphoma, Massachusetts General Hospital (MGH), Boston 08:50 CAR T in Myeloma: What […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-full.php","meta":{"footnotes":""},"class_list":["post-117","page","type-page","status-publish","hentry"],"meta_box":{"cpde2_sidebar_image_std":"","cpde2_sidebar_image_custom":"","cpde2_sidebar_image_alt":"","cpde2_subnav":"","cpde2_map_addresses":[],"cpde2_additional_page_sections":[]},"_links":{"self":[{"href":"https:\/\/www.cpd.utoronto.ca\/effectorcell\/wp-json\/wp\/v2\/pages\/117","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cpd.utoronto.ca\/effectorcell\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.cpd.utoronto.ca\/effectorcell\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.cpd.utoronto.ca\/effectorcell\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cpd.utoronto.ca\/effectorcell\/wp-json\/wp\/v2\/comments?post=117"}],"version-history":[{"count":1,"href":"https:\/\/www.cpd.utoronto.ca\/effectorcell\/wp-json\/wp\/v2\/pages\/117\/revisions"}],"predecessor-version":[{"id":169,"href":"https:\/\/www.cpd.utoronto.ca\/effectorcell\/wp-json\/wp\/v2\/pages\/117\/revisions\/169"}],"wp:attachment":[{"href":"https:\/\/www.cpd.utoronto.ca\/effectorcell\/wp-json\/wp\/v2\/media?parent=117"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}